Ludwig Deml

2.0k total citations
53 papers, 1.5k citations indexed

About

Ludwig Deml is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Ludwig Deml has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 22 papers in Virology and 21 papers in Epidemiology. Recurrent topics in Ludwig Deml's work include HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (19 papers) and vaccines and immunoinformatics approaches (7 papers). Ludwig Deml is often cited by papers focused on HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (19 papers) and vaccines and immunoinformatics approaches (7 papers). Ludwig Deml collaborates with scholars based in Germany, Austria and Netherlands. Ludwig Deml's co-authors include Ralf Wagner, Hans Wolf, Reinhold Schirmbeck, Marcus Graf, Hans Wolf, Cornelia Speth, Jörg Reimann, Jens Wild, Ralf Wagner and Manfred P. Dierich and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Virology.

In The Last Decade

Ludwig Deml

50 papers receiving 1.5k citations

Peers

Countries citing papers authored by Ludwig Deml

Since Specialization

Citations

This map shows the geographic impact of Ludwig Deml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludwig Deml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludwig Deml more than expected).

Fields of papers citing papers by Ludwig Deml

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludwig Deml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludwig Deml. The network helps show where Ludwig Deml may publish in the future.

Co-authorship network of co-authors of Ludwig Deml

This figure shows the co-authorship network connecting the top 25 collaborators of Ludwig Deml. A scholar is included among the top collaborators of Ludwig Deml based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludwig Deml. Ludwig Deml is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Performance of T-Track® SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells 2023 ·Diagnostics ·(unknown), (unknown), (unknown), Hans-Helmut Niller, Michael Dahm, (unknown), Thomas Zander, Friedhelm Struck, Erwin Soutschek, Ludwig Deml, (unknown), (unknown)	2
2	Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation 2021 ·Diagnostics ·Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, Kerstin Schäfer‐Eckart, (unknown), Stephan Mielke, Martin Schreder, Guido Kobbe, Inken Hilgendorf, Stefan Klein, Mareike Verbeek, Markus Ditschkowski, Martina Koch, Monika Lindemann, (unknown), Anne Rascle, (unknown), Ludwig Deml, Ralf Wagner, Daniel Wolff	1
3	Validation of the Suitability of Lophius Kits T-Track® CMV and T-Track® EBV to Assess the Functionality of Cell-Mediated Immunity (CMI) in Hemodialysis Patients 2012 ·Transplantation ·Bernhard Banas, Carsten A. Böger, (unknown), B. Krüger, (unknown), Mathias Schemmerer, (unknown), Ludwig Deml, (unknown), Benedikt Kramer	3
4	4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease† 2010 ·Inflammatory Bowel Diseases ·Leo R. Fitzpatrick, Ludwig Deml, Claudia Hofmann, Jeffrey Small, (unknown), (unknown), (unknown), Johann Leban, Aldo Ammendola	55
5	Early pregnancy/Preterm delivery 2009 ·Journal of Perinatal Medicine ·(unknown), J. W. Dudenhausen, K Friese, Luana Danti, (unknown), Federico Prefumo, Andrea Lojacono, (unknown), Ludwig Deml, Ulrich Zaehringer, (unknown), Apostolos Papageorgiou	1
6	Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes 2008 ·Virology ·Cornelia Speth, (unknown), (unknown), Jens Wild, Manfred P. Dierich, Hans Wolf, Josef Schroeder, Ralf Wagner, Ludwig Deml	11
7	Urea-Mediated Cross-Presentation of Soluble Epstein-Barr Virus BZLF1 Protein 2008 ·PLoS Pathogens ·(unknown), Regina Gary, Tanja Bauer, Juha Lindner, Petra Lindner, Birgit Weinberger, Wolfgang Jilg, Hans Wolf, Ludwig Deml	12
8	Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus 2006 ·Virology ·Seraphin Kuate, Christiane Stahl‐Hennig, Heribert Stoiber, Godwin Nchinda, (unknown), (unknown), Ulrike Sauermann, (unknown), Ludwig Deml, Ralf Ignatius, Steve Norley, Paul Rácz, Klara Tenner‐Racz, Ralph M. Steinman, Ralf Wagner, Klaus Überla	40
9	Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses 2004 ·Molecular Immunology ·Ludwig Deml, Cornelia Speth, Manfred P. Dierich, Hans Wolf, Ralf Wagner	115
10	Stable Transfected Drosophila Schneider-2 Cells as a Novel Tool to Produce Recombinant Antigens for Diagnostic, Therapeutic, and Preventive Purposes 2003 ·Humana Press eBooks ·Ludwig Deml, Ralf Wagner	2
11	Impact of Codon Usage Modification on T Cell Immunogenicity and Longevity of HIV-1 Gag-Specific DNA Vaccines 2002 ·Intervirology ·(unknown), Jens Wild, Ludwig Deml, Ralf Wagner	20
12	CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice 2002 ·European Journal of Immunology ·Florian Obermeier, Nadja Dunger, Ludwig Deml, Hans Herfarth, Jürgen Schölmerich, Werner Falk	109
13	Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection 2000 ·AIDS ·Martina Sester, Urban Sester, Hans Köhler, Thomas Schneider, Ludwig Deml, Ralf Wagner, Nikolaus Mueller‐Lantzsch, H.W. Pees, Andreas Meyerhans	28
14	Frequency of CD8+ T Lymphocytes Specific for Lytic and Latent Antigens of Epstein–Barr Virus in Healthy Virus Carriers 1999 ·Virology ·(unknown), (unknown), Ludwig Deml, Susanne Modrow, Hans Wolf, Wolfgang Jilg	28
15	Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells 1999 ·Journal of Virological Methods ·Ludwig Deml, (unknown), Jörg Reimann, Hans Wolf, Ralf Wagner	23
16	High level expression of hepatitis B virus surface antigen in stably transfected Drosophila Schneider-2 cells 1999 ·Journal of Virological Methods ·Ludwig Deml, Hans Wolf, Ralf Wagner	31
17	Recombinant Human Immunodeficiency Pr55gagVirus-like Particles Presenting Chimeric Envelope Glycoproteins Induce Cytotoxic T-Cells and Neutralizing Antibodies 1997 ·Virology ·Ludwig Deml, Reinhold Schirmbeck, Jörg Reimann, Hans Wolf, Ralf Wagner	65
18	Construction, Expression, and Immunogenicity of Chimeric HIV-1 Virus-like Particles 1996 ·Virology ·Ralf Wagner, Ludwig Deml, Reinhold Schirmbeck, (unknown), Jörg Reimann, Hans Wolf	69
19	Assembly and Extracellular Release of Chimeric HIV-1 Pr55gag Retrovirus-like Particles 1994 ·Virology ·Ralf Wagner, Ludwig Deml, (unknown), Gerhard Wanner, H. Wolf	51
20	Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses 1993 ·Journal of General Virology ·Ralf Wagner, (unknown), Ludwig Deml, Susanne Modrow, Hans Wolf	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact